Literature DB >> 15206894

Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.

Brock Matter1, Gang Wang, Roger Jones, Natalia Tretyakova.   

Abstract

G --> T transversion mutations in the p53 tumor suppressor gene are characteristic of smoking-related lung tumors, suggesting that these genetic changes may result from exposure to tobacco carcinogens. It has been previously demonstrated that the diol epoxide metabolites of bay region polycyclic aromatic hydrocarbons present in tobacco smoke, e.g., benzo[a]pyrene diol epoxide (BPDE), preferentially bind to the most frequently mutated guanine nucleotides within p53 codons 157, 158, 248, and 273 [Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Science 274, 430-432]. However, the methodology used in that work (ligation-mediated polymerase chain reaction in combination with the UvrABC endonuclease incision assay) cannot establish the chemical structures and stereochemical identities of BPDE-guanine lesions. In the present study, we employ a stable isotope-labeling HPLC-MS/MS approach [Tretyakova, N., Matter, B., Jones, R., and Shallop, A. (2002) Biochemistry 41, 9535-9544] to analyze the formation of diastereomeric N(2)-BPDE-dG lesions within double-stranded oligodeoxynucleotides representing p53 lung cancer mutational hotspots and their surrounding DNA sequences. (15)N-labeled dG was placed at defined positions within DNA duplexes containing 5-methylcytosine at all physiologically methylated sites, followed by (+/-)-anti-BPDE treatment and enzymatic hydrolysis of the adducted DNA to 2'-deoxynucleosides. Capillary HPLC-ESI(+)-MS/MS was used to establish the amounts of (-)-trans-N(2)-BPDE-dG, (+)-cis-N(2)-BPDE-dG, (-)-cis-N(2)-BPDE-dG, and (+)-trans-N(2)-BPDE-dG originating from the (15)N-labeled bases. We found that all four N(2)-BPDE-dG diastereomers were formed preferentially at the methylated CG dinucleotides, including the frequently mutated p53 codons 157, 158, 245, 248, and 273. The contributions of individual diastereomers to the total adducts number at a given site varied between 70.8 and 92.9% for (+)-trans-N(2)-BPDE-dG, 5.6 and 16.7% for (-)-trans-N(2)-BPDE-dG, 2.1 and 8.5% for (-)-cis-N(2)-BPDE-dG, and 0.5 and 8.3% for (+)-cis-N(2)-BPDE-dG. The relative yields of the minor N(2)-BPDE-dG stereoisomers were elevated at the sites of inefficient adduction, while the major (+)-trans-BPDE lesion was even more dominant at the frequently adducted sites. The introduction of 5-methyl groups at adjacent cytosine bases increased the yields of N(2)-BPDE-dG diastereomers, probably a result of favorable hydrophobic interactions between BPDE and 5-methylcytosine. The targeted formation of N(2)-BPDE-dG at (Me)CG dinucleotides within the p53 gene is consistent with the high prevalence of G --> T transversions at these sites in smoking-induced lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206894     DOI: 10.1021/tx049974l

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  22 in total

1.  Noncovalent DNA binding drives DNA alkylation by leinamycin: evidence that the Z,E-5-(thiazol-4-yl)-penta-2,4-dienone moiety of the natural product serves as an atypical DNA intercalator.

Authors:  Mostafa I Fekry; Jozsef Szekely; Sanjay Dutta; Leonid Breydo; Hong Zang; Kent S Gates
Journal:  J Am Chem Soc       Date:  2011-10-18       Impact factor: 15.419

Review 2.  Biological properties of single chemical-DNA adducts: a twenty year perspective.

Authors:  James C Delaney; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2007-12-12       Impact factor: 3.739

3.  Mapping three guanine oxidation products along DNA following exposure to three types of reactive oxygen species.

Authors:  Brock Matter; Christopher L Seiler; Kristopher Murphy; Xun Ming; Jianwei Zhao; Bruce Lindgren; Roger Jones; Natalia Tretyakova
Journal:  Free Radic Biol Med       Date:  2018-04-25       Impact factor: 7.376

4.  Mass spectrometry based approach to study the kinetics of O6-alkylguanine DNA alkyltransferase-mediated repair of O6-pyridyloxobutyl-2'-deoxyguanosine adducts in DNA.

Authors:  Delshanee Kotandeniya; Dan Murphy; Uthpala Seneviratne; Rebecca Guza; Anthony Pegg; Sreenivas Kanugula; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2011-09-29       Impact factor: 3.739

Review 5.  Mass spectrometry of structurally modified DNA.

Authors:  Natalia Tretyakova; Peter W Villalta; Srikanth Kotapati
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

6.  Can 5-methylcytosine analogues with extended alkyl side chains guide DNA methylation?

Authors:  D Kotandeniya; C L Seiler; J Fernandez; S S Pujari; L Curwick; K Murphy; S Wickramaratne; S Yan; D Murphy; Yuk Y Sham; N Y Tretyakova
Journal:  Chem Commun (Camb)       Date:  2018-01-25       Impact factor: 6.222

7.  Cytosine methylation effects on the repair of O6-methylguanines within CG dinucleotides.

Authors:  Rebecca Guza; Linan Ma; Qingming Fang; Anthony E Pegg; Natalia Tretyakova
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

8.  The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.

Authors:  James Glick; Wennan Xiong; Yiqing Lin; Anne M Noronha; Christopher J Wilds; Paul Vouros
Journal:  J Mass Spectrom       Date:  2009-08       Impact factor: 1.982

9.  Kinetics of O(6)-pyridyloxobutyl-2'-deoxyguanosine repair by human O(6)-alkylguanine DNA alkyltransferase.

Authors:  Delshanee Kotandeniya; Daniel Murphy; Shuo Yan; Soobong Park; Uthpala Seneviratne; Joseph S Koopmeiners; Anthony Pegg; Sreenivas Kanugula; Fekadu Kassie; Natalia Tretyakova
Journal:  Biochemistry       Date:  2013-05-31       Impact factor: 3.162

10.  Quantitation of enantiomers of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]-pyrene in human urine: evidence supporting metabolic activation of benzo[a]pyrene via the bay region diol epoxide.

Authors:  Stephen S Hecht; Jon Bradley Hochalter
Journal:  Mutagenesis       Date:  2014-07-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.